EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of HPSE/SDC-2 axis-induced epithelial-mesenchymal transition for treating IC/BPS

Zhengsen Chen, Yuting He iD, Junjie Zhang, Qingyu Ge, Tianpeng Du, Zongyao Fan, Junyl Zhou, Xin Yang, Baixin Shen, Zhongqing Wei

PLOS One · 2025

DOI: 10.1371/journal.pone.0321730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zhengsen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Cystitis, Interstitial, Glucuronidase, Syndecan-2. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Science and Technology Support Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial cystitis/bladder pain syndrome (IC/BPS) plagues patients and clinicians with its unclear etiology and pathogenesis, and ineffective treatments. Destruction of epithelial tissue and proliferation of interstitial tissue are typical pathological features of IC/BPS, in which epithelial-mesenchymal transition (EMT) may play an important role. Both the increased urination frequency observed in mice with acute cystitis induced by cyclophosphamide (CYP) and the disruption of the anti-leakage barrier in urothelial cells induced by LPS are associated with the occurrence of EMT. The expression of heparanase 1 (HPSE) and syndecan-2 (SDC-2) is up-regulated in the bladder mucosa of patients with IC, and both of them can promote the development of EMT. Improvement of lower urinary tract symptoms and restoration of the uroepithelial cell anti-leakage barrier in mice with CYP-induced cystitis after treatment with the HPSE inhibitor OGT2115 and inhibited the development of EMT. We then verified that HPSE binds to SDC-2 and that SDC-2 is a key intermediate protein in the pro-EMT role of HPSE, and that EMT was inhibited by knockdown of SDC-2. SDC-2 exerts its biological function by inhibiting the ubiquitinated degradation of TGF-βR1. Here we identified a novel mechanism by which the HPSE/ SDC-2 axis promotes EMT development and thus causes epithelial dysfunction and altered voiding behavior, providing a new direction for the treatment of IC/BPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionCystitis, InterstitialGlucuronidaseSyndecan-2AnimalsHumansMiceFemaleUrinary BladderCyclophosphamideUrotheliumMaleHeparanase

Substanzen

GlucuronidaseSyndecan-2CyclophosphamideHeparanase

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Urology, The Second Clinical Medical College of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Yuting He

Förderung

  • the National Natural Science Foundation of China
  • Science and Technology Support Program of Jiangsu Province

Zitieren

APA

Chen, Z., He, Y., Zhang, J., Ge, Q., Du, T., Fan, Z., Zhou, J., Yang, X., Shen, B., & Wei, Z. (2025). Inhibition of HPSE/SDC-2 axis-induced epithelial-mesenchymal transition for treating IC/BPS. PLOS One. https://doi.org/10.1371/journal.pone.0321730

Vancouver

Chen Z, He Y, Zhang J, Ge Q, Du T, Fan Z, et al. Inhibition of HPSE/SDC-2 axis-induced epithelial-mesenchymal transition for treating IC/BPS. PLOS One. 2025. doi:10.1371/journal.pone.0321730

BibTeX
@article{Chen2025,
  author = {Chen, Zhengsen and He, Yuting and Zhang, Junjie and Ge, Qingyu and Du, Tianpeng and Fan, Zongyao and Zhou, Junyl and Yang, Xin and Shen, Baixin and Wei, Zhongqing},
  title = {Inhibition of HPSE/SDC-2 axis-induced epithelial-mesenchymal transition for treating IC/BPS},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321730}
}
Kostenlos starten →